大奖888生化有限公司
大奖888·(中国)官网
首页
关于我们
公司简介
管理团队
企业荣誉
研发和生产基地
质量与合规
知识产权保护
环境,健康与安全
业务平台
多肽CRDMO平台
寡核苷酸CDMO平台
服务与解决方案
多肽新药发现合成服务
多肽新药CMC开发服务
多肽仿制药开发服务
美容肽研发和生产服务
寡核苷酸新药发现合成服务
寡核苷酸新药CMC服务
GMP生产服务
全球申报事务药学支持
研发全时(FTE)服务
产品
多肽原料药产品
目录肽产品
新闻和活动
公司新闻
行业动态
展会动态
品牌活动
促销活动
资源中心
客户案例
白皮书
媒体中心
CRDMO业务手册
职业发展
人才政策
招聘职位
English
目录肽产品
您现在的位置:
首页
-
产品
-
目录肽产品
-
Defensins
多肽原料药产品
目录肽产品
您现在的位置:
首页
-
产品
-
目录肽产品
-
Defensins
Defensins
DEFS-005A
b-Defensin-3, human
Gly-Ile-Ile-Asn-Thr-Leu-Gln-Lys-Tyr-Tyr-Cys-Arg-Val-Arg-Gly-Gly-Arg-Cys-Ala-Val-Leu-Ser-Cys-Leu-Pro-Lys-Glu-Glu-Gln-Ile-Gly-Lys-Cys-Ser-Thr-Arg-Gly-Arg-Lys-Cys-Cys-Arg-Arg-Lys-Lys(Cys11&Cys40 bridge , Cys18&Cys33 bridge , Cys23&Cys41 bridge)
DEFS-005B
b-Defensin-3, human
Gly-Ile-Ile-Asn-Thr-Leu-Gln-Lys-Tyr-Tyr-Cys-Arg-Val-Arg-Gly-Gly-Arg-Cys-Ala-Val-Leu-Ser-Cys-Leu-Pro-Lys-Glu-Glu-Gln-Ile-Gly-Lys-Cys-Ser-Thr-Arg-Gly-Arg-Lys-Cys-Cys-Arg-Arg-Lys-Lys(Cys11&Cys40 bridge , Cys18&Cys33 bridge , Cys23&Cys41 bridge)
DEFS-001A
Defensin (human) HNP-2
Cys-Tyr-Cys-Arg-Ile-Pro-Ala-Cys-Ile-Ala-Gly-Glu-Arg-Arg-Tyr-Gly-Thr-Cys-Ile-Tyr-Gln-Gly-Arg-Leu-Trp-Ala-Phe-Cys-Cys(Cys1&Cys29 bridge,Cys3&Cys18 bridge Cys8&Cys28 bridge)
DEFS-001B
Defensin (human) HNP-2
Cys-Tyr-Cys-Arg-Ile-Pro-Ala-Cys-Ile-Ala-Gly-Glu-Arg-Arg-Tyr-Gly-Thr-Cys-Ile-Tyr-Gln-Gly-Arg-Leu-Trp-Ala-Phe-Cys-Cys(Cys1&Cys29 bridge , Cys3&Cys18 bridge Cys8&Cys28 bridge)
DEFS-002A
Defensin-1 (human) HNP-1
Ala-Cys-Tyr-Cys-Arg-Ile-Pro-Ala-Cys-Ile-Ala-Gly-Glu-Arg-Arg-Tyr-Gly-Thr-Cys-Ile-Tyr-Gln-Gly-Arg-Leu-Trp-Ala-Phe-Cys-Cys(Cys2&Cys30 bridge , Cys4&Cys19 bridge , Cys 9&Cys29 bridge)
DEFS-002B
Defensin-1 (human) HNP-1
Ala-Cys-Tyr-Cys-Arg-Ile-Pro-Ala-Cys-Ile-Ala-Gly-Glu-Arg-Arg-Tyr-Gly-Thr-Cys-Ile-Tyr-Gln-Gly-Arg-Leu-Trp-Ala-Phe-Cys-Cys(Cys2&Cys30 bridge , Cys4&Cys19 bridge , Cys 9&Cys29 bridge)
DEFS-003A
b-Defensin-1, human
Asp-His-Tyr-Asn-Cys-Val-Ser-Ser-Gly-Gly-Gln-Cys-Leu-Tyr-Ser-Ala-Cys-Pro-Ile-Phe-Thr-Lys-Ile-Gln-Gly-Thr-Cys-Tyr-Arg-Gly-Lys-Ala-Lys-Cys-Cys-Lys(Cys5&Cys34 bridge , Cys12&Cys27 bridge , Cys17&Cys35 bridge)
DEFS-003B
b-Defensin-1, human
Asp-His-Tyr-Asn-Cys-Val-Ser-Ser-Gly-Gly-Gln-Cys-Leu-Tyr-Ser-Ala-Cys-Pro-Ile-Phe-Thr-Lys-Ile-Gln-Gly-Thr-Cys-Tyr-Arg-Gly-Lys-Ala-Lys-Cys-Cys-Lys(Cys5&Cys34 bridge , Cys12&Cys27 bridge , Cys17&Cys35 bridge)
DEFS-006A
b-Defensin-4, human
Glu-Leu-Asp-Arg-Ile-Cys-Gly-Tyr-Gly-Thr-Ala-Arg-Cys-Arg-Lys-Lys-Cys-Arg-Ser-Gln-Glu-Tyr-Arg-Ile-Gly-Arg-Cys-Pro-Asn-Thr-Tyr-Ala-Cys-Cys-Leu-Arg-Lys(Cys6&Cys33 bridge , Cys13&Cys27 bridge Cys17&34 bridge)
DEFS-006B
b-Defensin-4, human
Glu-Leu-Asp-Arg-Ile-Cys-Gly-Tyr-Gly-Thr-Ala-Arg-Cys-Arg-Lys-Lys-Cys-Arg-Ser-Gln-Glu-Tyr-Arg-Ile-Gly-Arg-Cys-Pro-Asn-Thr-Tyr-Ala-Cys-Cys-Leu-Arg-Lys(Cys6&Cys33 bridge , Cys13&Cys27 bridge Cys17&34 bridge)
DEFS-004A
b-Defensin-2, human
Gly-Ile-Gly-Asp-Pro-Val-Thr-Cys-Leu-Lys-Ser-Gly-Ala-Ile-Cys-His-Pro-Val-Phe-Cys-Pro-Arg-Arg-Tyr-Lys-Gln-Ile-Gly-Thr-Cys-Gly-Leu-Pro-Gly-Thr-Lys-Cys-Cys-Lys-Lys-Pro(Cys8&Cys37 bridge , Cys20&Cys38 bridge , Cys15&Cys30 bridge)
DEFS-004B
b-Defensin-2, human
Gly-Ile-Gly-Asp-Pro-Val-Thr-Cys-Leu-Lys-Ser-Gly-Ala-Ile-Cys-His-Pro-Val-Phe-Cys-Pro-Arg-Arg-Tyr-Lys-Gln-Ile-Gly-Thr-Cys-Gly-Leu-Pro-Gly-Thr-Lys-Cys-Cys-Lys-Lys-Pro(Cys8&Cys37 bridge , Cys20&Cys38 bridge , Cys15&Cys30 bridge)
DEFS-007A
Defensin HNP-3 (human)
Asp-Cys-Tyr-Cys-Arg-Ile-Pro-Ala-Cys-Ile-Ala-Gly-Glu-Arg-Arg-Tyr-Gly-Thr-Cys-Ile-Tyr-Gln-Gly-Arg-Leu-Trp-Ala-Phe-Cys-Cys(Cys2 and Cys30/Cys4 and Cys19/Cys9 and Cys29 Bridge)
DEFS-007B
Defensin HNP-3 (human)
Asp-Cys-Tyr-Cys-Arg-Ile-Pro-Ala-Cys-Ile-Ala-Gly-Glu-Arg-Arg-Tyr-Gly-Thr-Cys-Ile-Tyr-Gln-Gly-Arg-Leu-Trp-Ala-Phe-Cys-Cys(Cys2 and Cys30/Cys4 and Cys19/Cys9 and Cys29 Bridge)
DEFS-007C
Defensin HNP-3 (human)
Asp-Cys-Tyr-Cys-Arg-Ile-Pro-Ala-Cys-Ile-Ala-Gly-Glu-Arg-Arg-Tyr-Gly-Thr-Cys-Ile-Tyr-Gln-Gly-Arg-Leu-Trp-Ala-Phe-Cys-Cys(Cys2 and Cys30/Cys4 and Cys19/Cys9 and Cys29 Bridge)
DEFS-008A
α-Defensin 6
Ala-Phe-Thr-Cys-His-Cys-Arg-Arg-Ser-Cys-Tyr-Ser-Thr-Glu-Tyr-Ser-Tyr-Gly-Thr-Cys-Thr-Val-Met-Gly-Ile-Asn-His-Arg-Phe-Cys-Cys-Leu(Cys4 and Cys31/Cys6 and Cys20/Cys10 and Cys30 Bridge)
DEFS-008B
α-Defensin 6
Ala-Phe-Thr-Cys-His-Cys-Arg-Arg-Ser-Cys-Tyr-Ser-Thr-Glu-Tyr-Ser-Tyr-Gly-Thr-Cys-Thr-Val-Met-Gly-Ile-Asn-His-Arg-Phe-Cys-Cys-Leu(Cys4 and Cys31/Cys6 and Cys20/Cys10 and Cys30 Bridge)
DEFS-008C
α-Defensin 6
Ala-Phe-Thr-Cys-His-Cys-Arg-Arg-Ser-Cys-Tyr-Ser-Thr-Glu-Tyr-Ser-Tyr-Gly-Thr-Cys-Thr-Val-Met-Gly-Ile-Asn-His-Arg-Phe-Cys-Cys-Leu(Cys4 and Cys31/Cys6 and Cys20/Cys10 and Cys30 Bridge)
上一页
1
下一页
0571-86737011
请填写您的正确信息,我们会及时与您联系
您的姓名
*
联系电话
*
电子邮箱
*
微信
单位名称
省份
*
产品类型
*
是否出口
*
产品需求
*
网站首页
大奖888